| Literature DB >> 4048205 |
Abstract
The draft guideline sets forth acceptable conditions for use of the Limulus Amebocyte Lysate (LAL) test. It also describes procedures for using this methodology as an end-product endotoxin test for human (including biological products) and animal injectable drugs, and medical devices. Manufacturers are allowed to switch from the rabbit pyrogen test to the LAL test, without preclearance from FDA, if they follow the guideline.Entities:
Mesh:
Substances:
Year: 1985 PMID: 4048205
Source DB: PubMed Journal: Prog Clin Biol Res ISSN: 0361-7742